From the electronic medical record, 910 patients were identified as having “Celiac Disease Comprehensive Panel” or “Tissue Transglutaminase Ab, IgA” and “Immunoglobulin A” ordered from Quest Diagnostics between January 2017 and June 2022. The gene discussed is CD79A; the disease is celiac disease.